NeuMedics is actively listed on crowd funding sites, Healthios, Gust, and Angel MD. Proceeds from these sources will be used to advance NeuMedics development program and provide data that is both conclusive and can translate into clinical trials.
NeuMedics intends to commit 10-15% of its outstanding shares and use the funds to complete :
- Characterization of NM108 as an eye drop
- Completion of pivotal pre clinical “killer experiments”, necessary to support an IND